These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15481991)

  • 21. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
    Luo R; Wang J; Zhao L; Lu N; You Q; Guo Q; Li Z
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1334-8. PubMed ID: 24507925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells.
    Kitagawa S; Nabekura T; Kamiyama S
    J Pharm Pharmacol; 2004 Aug; 56(8):1001-5. PubMed ID: 15285844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the inhibitory activity, in vitro, of baicalein and baicalin against skin fungi and bacteria].
    Yang D; Hu H; Huang S; Chaumont JP; Millet J
    Zhong Yao Cai; 2000 May; 23(5):272-4. PubMed ID: 12575154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
    Zhao Y; Bu L; Yan H; Jia W
    Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity.
    Woo KJ; Lim JH; Suh SI; Kwon YK; Shin SW; Kim SC; Choi YH; Park JW; Kwon TK
    Immunobiology; 2006; 211(5):359-68. PubMed ID: 16716805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-glycoprotein activity and biological response.
    Vaalburg W; Hendrikse NH; Elsinga PH; Bart J; van Waarde A
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):257-60. PubMed ID: 16043202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships.
    Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH
    ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
    Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
    Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
    Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
    Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action.
    Sterz K; Möllmann L; Jacobs A; Baumert D; Wiese M
    ChemMedChem; 2009 Nov; 4(11):1897-911. PubMed ID: 19777523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
    Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH
    Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
    Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
    Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells.
    Yano S; Yanagawa H; Hanibuchi M; Pai K; Nishioka Y; Tsuruo T; Sone S
    J Med Invest; 1998 Feb; 44(3-4):185-91. PubMed ID: 9597807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced potency of daunorubicin against multidrug resistant subline KB-ChR-8-5-11 by a pulsed magnetic field.
    Liang Y; Hannan CJ; Chang BK; Schoenlein PV
    Anticancer Res; 1997; 17(3C):2083-8. PubMed ID: 9216668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.